Latest News and Press Releases

Longeveron supports the passing of the Mikaela Naylon Give Kids a Chance Act which reauthorizes the Rare Pediatric Disease Priority Review Voucher Program.

DETROIT, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells, a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the...

Longeveron granted FDA Type C meeting ahead of Q3 2026 data readout of pivotal clinical trial for stem cell therapy in hypoplastic left heart syndrome.

Gift of Life marked a milestone with a ribbon-cutting celebrating its expanded Adelson Collection Center and Center for Cell and Gene Therapy.

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit solely focused on accelerating a cure for type 1 diabetes, announced the release of the 14th...

Longeveron presents new MRI biomarker data linking neuroinflammation to clinical outcomes in patients with mild Alzheimer's disease at CTAD 2025.

Gift of Life Marrow Registry hosted its annual Los Angeles Gala highlighting lifesaving donors and transplant recipients

Longeveron BOD appoints Interim CEO and Executive Chairman of BOD. Board plans to conduct a national search to identify a permanent CEO.

Gift of Life Marrow Registry celebrated the successful launch of its new Hero Gum campaign at Citi Field on August 1 during the New York Mets game.

$NSTM: NovelStem Announces Material Developments and Strategic Repositioning of the Company.